| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|---|---|---|---|---|---|---|---|---|---|
General and administrative expense | ||||||||||
9,982 | 16,871 | 17,131 | 18,692 | 17,554 | 18,970 | 21,644 | 19,473 | 21,168 | 20,847 | - |
Revenue | ||||||||||
- | - | - | - | - | - | - | - | - | - | 34,839 |
Cost of sales | ||||||||||
- | - | - | - | - | - | - | - | - | - | 13,811 |
Selling, general and administrative | ||||||||||
- | - | - | - | - | - | - | - | - | - | 37,214 |
Total operating expenses | ||||||||||
- | - | - | - | - | - | - | - | - | - | 51,025 |
Operating loss | ||||||||||
-9,982 | -16,871 | -17,131 | -18,692 | -17,554 | -18,970 | -21,644 | -19,473 | -21,168 | -20,847 | -16,186 |
Other income (loss), net | ||||||||||
12,255 | -5,158 | -339 | -1,682 | 217 | 31,657 | 383 | 9,338 | -6,145 | 74,809 | 108,881 |
Interest income | ||||||||||
2,044 | 2,806 | 3,876 | 2,075 | 1,935 | 1,901 | 2,646 | 2,926 | 1,424 | 718 | 480 |
Interest expense | ||||||||||
14,023 | 16,067 | 8,620 | 4,634 | 4,523 | 4,402 | 4,303 | 5,636 | 5,971 | 5,737 | 3,164 |
Equity income (loss), net | ||||||||||
64,267 | 19,661 | -66,358 | 671 | -39,599 | -15,335 | -12,607 | -26,517 | 142,457 | -22,334 | -23,227 |
Net income (loss) before income taxes | ||||||||||
54,561 | -15,629 | -88,572 | -22,262 | -59,524 | -5,149 | -35,525 | -39,362 | 110,597 | 26,609 | 66,784 |
Income tax benefit (expense) | ||||||||||
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14 |
Net income from continuing operations | ||||||||||
- | - | - | - | - | - | - | - | - | - | 66,798 |
Income from discontinued operations, net of tax | ||||||||||
- | - | - | - | - | - | - | - | - | - | 1,975 |
Net income (loss) | ||||||||||
54,561 | -15,629 | -88,572 | -22,262 | -59,524 | -5,149 | -35,525 | -39,362 | 110,597 | 26,609 | 68,773 |
Net income (loss) per share: | ||||||||||
Net income attributable to noncontrolling interest | ||||||||||
- | - | - | - | - | - | - | - | - | - | 1,163 |
Net loss | ||||||||||
- | - | - | - | - | - | - | - | - | - | 67,610 |
Net income from continuing operations attributable to Safeguard Scientifics, Inc. common shareholders | ||||||||||
- | - | - | - | - | - | - | - | - | - | 3.26 |
Net income from discontinued operations attributable to Safeguard Scientifics, Inc. common shareholders | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0.07 |
Basic (in dollars per share) | ||||||||||
2.64 | -0.76 | -4.34 | -1.09 | -2.85 | -0.25 | -1.66 | -1.88 | 5.33 | 1.30 | 3.33 |
Net income from continuing operations attributable to Safeguard Scientifics, Inc. common shareholders | ||||||||||
- | - | - | - | - | - | - | - | - | - | 3.08 |
Net income from discontinued operations attributable to Safeguard Scientifics, Inc. common shareholders | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0.06 |
Diluted (in dollars per share) | ||||||||||
2.64 | -0.76 | -4.34 | -1.09 | -2.85 | -0.25 | -1.66 | -1.88 | 4.74 | 1.24 | 3.14 |
Weighted average shares used in computing income (loss) per share: | ||||||||||
Basic (in shares) | ||||||||||
20,636 | 20,544 | 20,430 | 20,343 | 20,874 | 20,975 | 21,362 | 20,974 | 20,764 | 20,535 | 20,308 |
Diluted (in shares) | ||||||||||
20,636 | 20,544 | 20,430 | 20,343 | 20,874 | 20,975 | 21,362 | 20,974 | 24,522 | 21,507 | 22,383 |
Net income from continuing operations | ||||||||||
- | - | - | - | - | - | - | - | - | - | 66,240 |
Net income from discontinued operations | ||||||||||
- | - | - | - | - | - | - | - | - | - | 1,370 |
Net income attributable to Safeguard Scientifics, Inc. | ||||||||||
- | - | - | - | - | - | - | - | - | - | 67,610 |